Armodafinil vs Huperzine A

Mechanism

The isolated R-enantiomer of racemic modafinil, sharing the same primary mechanism — selective inhibition of the dopamine transporter (DAT) — but with distinct pharmacokinetics. The R-enantiomer has a terminal half-life of ~15 hours vs. ~4-5 hours for the S-enantiomer, resulting in 33-40% higher plasma AUC compared to equimolar racemic modafinil. This translates to more sustained wakefulness-promoting activity throughout the day. Same downstream activation of orexinergic, histaminergic, and noradrenergic pathways as modafinil.

Standard Dosing

75-150 mg once daily (for educational context only — prescription medication in most jurisdictions)

Timing

Early morning. 150 mg armodafinil provides comparable late-day wakefulness to 200 mg modafinil. Food delays Tmax by ~2-4 hours but does not affect total absorption. Half-life approximately 15-16.5 hours.

Cycle Duration

Same as modafinil; not typically cycled in clinical use.

Side Effects

• Headache
• Nausea
• Dizziness
• Insomnia (more pronounced than modafinil due to longer half-life)
• Anxiety
• Dry mouth
• Diarrhea
• Stevens-Johnson syndrome (very rare)

Contraindications

• Same as modafinil: mitral valve prolapse, left ventricular hypertrophy, severe hepatic impairment, severe anxiety/psychotic disorders, hypersensitivity, pregnancy

Best Stacking Partners

Mechanism

Potent, selective, and reversible inhibitor of acetylcholinesterase (AChE), derived from the club moss Huperzia serrata. Exhibits preference for the tetrameric G4 form of AChE predominant in the mammalian brain. Eight-fold more potent than donepezil and two-fold more potent than rivastigmine at AChE inhibition. Crosses the BBB efficiently. Also antagonizes NMDA receptors at high concentrations and provides neuroprotection via attenuation of oxidative stress, regulation of apoptotic proteins (Bcl-2, Bax, P53, caspase-3), and upregulation of NGF.

Standard Dosing

50-200 mcg twice daily

Timing

Morning and early afternoon. With or without food.

Cycle Duration

Cycle 2-4 weeks on, 1-2 weeks off to prevent AChE downregulation

Side Effects

• Nausea
• Diarrhea
• Sweating
• Blurred vision
• Muscle twitching
• Bradycardia at high doses

Contraindications

• Bradycardia
• Asthma/COPD (cholinergic bronchoconstriction)
• GI obstruction
• Concurrent use of prescription AChE inhibitors
• Peptic ulcer disease

Best Stacking Partners